{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:30:44Z","timestamp":1790742644973,"version":"4.1.0"},"reference-count":158,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals S.A"},{"name":"GlaxoSmithKline Biologicals S.A"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2073146","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T19:04:41Z","timestamp":1653591881000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Hepatitis A in the Eastern Mediterranean Region: a comprehensive review"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-7203","authenticated-orcid":false,"given":"Selim","family":"Badur","sequence":"first","affiliation":[{"name":"GSK, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-6173","authenticated-orcid":false,"given":"Serdar","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"GSK, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-9730","authenticated-orcid":false,"given":"Mohammad","family":"AbdelGhany","sequence":"additional","affiliation":[{"name":"GSK, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-5034","authenticated-orcid":false,"given":"Mansour","family":"Khalaf","sequence":"additional","affiliation":[{"name":"GSK, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-1647","authenticated-orcid":false,"given":"Youness","family":"Lagoubi","sequence":"additional","affiliation":[{"name":"GSK, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-466X","authenticated-orcid":false,"given":"Onur","family":"Ozudogru","sequence":"additional","affiliation":[{"name":"GSK, Dubai, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-6024","authenticated-orcid":false,"given":"Kashif","family":"Hanif","sequence":"additional","affiliation":[{"name":"GSK, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-9653","authenticated-orcid":false,"given":"Debasish","family":"Saha","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"World Health Organization. The immunological basis for immunization series: module 18: hepatitis A; 2011 [accessed 2021 Feb 21]. https:\/\/apps.who.int\/iris\/handle\/10665\/44570"},{"issue":"28","key":"e_1_3_4_3_1","first-page":"261","article-title":"WHO position paper on hepatitis A vaccines \u2013 June 2012","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. WHO position paper on hepatitis A vaccines \u2013 June 2012. Wkly Epidemiol Rec. 2012;87(28\/29):261\u201317.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_4_4_1","first-page":"125","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Foster MA","year":"2015","unstructured":"Foster MA, Penina Haber P, Nelson NP, Hepatitis A. In: Hamborsky J, Kroger A, Wolfe Seditors, Epidemiology and prevention of vaccine-preventable diseases, 13. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/hepa.pdf: Center for Disease Control and Prevention. Washington DC: Public Health Foundation;2015, pp. 125\u201342","edition":"13"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7643-8558-3_6"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.034"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/49.6.333"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis710"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25687"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.006"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.09.020"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-072X-10-57"},{"key":"e_1_3_4_13_1","unstructured":"World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility : a systematic review. WHO\/IVB\/10.012.010; 2010 [accessed 2020 Nov 4]. https:\/\/apps.who.int\/iris\/handle\/10665\/70180"},{"key":"e_1_3_4_14_1","unstructured":"World Health Organization. Regional office for the Eastern Mediterranean. [accessed 2020 Nov 4]. http:\/\/www.emro.who.int\/countries.html"},{"key":"e_1_3_4_15_1","unstructured":"The World Bank. World Bank country and lending groups. [accessed 2020 Nov 4]. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01242-8"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.44695"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.037"},{"key":"e_1_3_4_19_1","first-page":"e1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;6:e1000097.","journal-title":"BMJ"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2015.7.12457"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.103425"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.7371"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2010.00800.x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1997.200"},{"issue":"9","key":"e_1_3_4_25_1","first-page":"678","article-title":"Hepatitis A in Saudi Arabia: a comparative sero-epidemiological study","volume":"20","author":"Al-Faleh F","year":"1999","unstructured":"Al-Faleh F, Al-Jeffri M, Ramia S, Al-Rashed RS, Arif MA, Mohammed OM, Bakhsh MH, Al-Freihi HM, Aljumah AA, Rezeig MA, et al. Hepatitis A in Saudi Arabia: a comparative sero-epidemiological study. Saudi Med J. 1999;20(9):678\u201381.","journal-title":"Saudi Med J"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2003.367"},{"key":"e_1_3_4_27_1","unstructured":"Alghamdi A Khalil M Alyahia O. Serological approach to need assessment for hepatitis A vaccination in primary schools in Al-Qassim. King AbdulAziz City for Science and Technology; 2004 [accessed 2020 Nov 4]. https:\/\/www.researchgate.net\/publication\/266949043_Serological_approach_to_need_assessment_for_hepatitis_A_vaccination_in_primary_schools_in_Al-Qassim"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1997.32"},{"key":"e_1_3_4_29_1","first-page":"202","article-title":"An outbreak of acute hepatitis A infection in rural Saudi Arabia","volume":"11","author":"Al-Majed SA","year":"1990","unstructured":"Al-Majed SA, Bakir TM, Al-Aska A, Ayoola B. An outbreak of acute hepatitis A infection in rural Saudi Arabia. Trop Gastroenterol. 1990;11:202\u201305.","journal-title":"Trop Gastroenterol"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/508826"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.04.038"},{"key":"e_1_3_4_32_1","first-page":"396","article-title":"Profile of viral hepatitis in Saudi Arabia","volume":"24","author":"Alshabanat A","year":"2013","unstructured":"Alshabanat A, Albacker R, Basalamah A, Salamah A, Al-Frayh A. Profile of viral hepatitis in Saudi Arabia. Biomed Res. 2013;24:396\u201399.","journal-title":"Biomed Res"},{"key":"e_1_3_4_33_1","first-page":"Cr52","article-title":"Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital","volume":"14","author":"Al-Tawfiq JA","year":"2008","unstructured":"Al-Tawfiq JA, Anani A. Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit. 2008;14:Cr52\u20136.","journal-title":"Med Sci Monit"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1996.11813044"},{"key":"e_1_3_4_35_1","first-page":"93","article-title":"Reduction in the prevalence of antibody to hepatitis A virus among young Saudi adults: implications for hepatitis A vaccine","volume":"1","author":"Arif M","year":"1995","unstructured":"Arif M, Al-Faleh FZ, Al-Frayh AR, Ramia S. Reduction in the prevalence of antibody to hepatitis A virus among young Saudi adults: implications for hepatitis A vaccine. Saudi J Gastroenterol. 1995;1:93\u201396.","journal-title":"Saudi J Gastroenterol"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890190107"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890190207"},{"key":"e_1_3_4_38_1","first-page":"95","article-title":"Serological profile of sporadic acute viral hepatitis in an area of hyper-endemic hepatitis B virus infection","volume":"7","author":"Ayoola A","year":"2001","unstructured":"Ayoola A, Aderoju A, Gadour MO, Al-Hazmi M, Hamza MK, Ene D, Hafeez M, Anderson D, Riddell M. Serological profile of sporadic acute viral hepatitis in an area of hyper-endemic hepatitis B virus infection. Saudi J Gastroenterol. 2001;7:95\u2013102.","journal-title":"Saudi J Gastroenterol"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.13005\/bbra\/903"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1995-7645(10)60068-5"},{"key":"e_1_3_4_41_1","first-page":"945","article-title":"Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia","volume":"21","author":"Fathalla SE","year":"2000","unstructured":"Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J. 2000;21:945\u201349.","journal-title":"Saudi Med J"},{"key":"e_1_3_4_42_1","first-page":"1515","article-title":"Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia","volume":"27","author":"Jaber SM","year":"2006","unstructured":"Jaber SM. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Saudi Med J. 2006;27:1515\u201322.","journal-title":"Saudi Med J"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1998.18"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/168.7.565"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.03.027"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(86)93633-9"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1990.tb11439.x"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.26719\/2011.17.10.754"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.19311v2"},{"key":"e_1_3_4_50_1","first-page":"160","article-title":"HAV in Isfahan province: a population-based study","volume":"29","author":"Ataei B","year":"2008","unstructured":"Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, Adibi P. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008;29:160\u201362.","journal-title":"Trop Gastroenterol"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.10157"},{"key":"e_1_3_4_52_1","first-page":"192","article-title":"Prevalence of hepatitis A virus infection in a HIV positive community","volume":"48","author":"Davoudi S","year":"2010","unstructured":"Davoudi S, Rasoolinejad M, Jafari S, Erfanzadeh M, Foroughi M, Hajiabdolbaghi M, Mohraz M. Prevalence of hepatitis A virus infection in a HIV positive community. Acta Med Iran. 2010;48:192\u201395.","journal-title":"Acta Med Iran"},{"key":"e_1_3_4_53_1","first-page":"S56","article-title":"Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran","volume":"19","author":"Farajzadegan Z","year":"2014","unstructured":"Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, Mirmoghtadaee P, Hovsepian S, Mostafavi S-N. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014;19:S56\u201363.","journal-title":"J Res Med Sci"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.32215"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815001302"},{"key":"e_1_3_4_56_1","first-page":"100","article-title":"Seroprevalence of hepatitis A virus among Iranian soldiers","volume":"9","author":"Izadi M","year":"2016","unstructured":"Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016;9:100\u201304.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2017.74"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/9798.5515"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:EJEP.0000020345.37091.cd"},{"key":"e_1_3_4_60_1","first-page":"99","article-title":"Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study","volume":"13","author":"Merat S","year":"2010","unstructured":"Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13:99\u2013104.","journal-title":"Arch Iran Med"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.37447"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2012.05.013"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.36437"},{"key":"e_1_3_4_64_1","first-page":"137","article-title":"Seroprevalence of hepatitis A among students enrolled in Tehran University of Medical Sciences during 2011","volume":"5","author":"Rabiee A","year":"2013","unstructured":"Rabiee A, Nikayin S, Hashemi SR, Mohaghegh M, Amini M, Rabiee R, Merat S. Seroprevalence of hepatitis A among students enrolled in Tehran University of Medical Sciences during 2011. Middle East J Dig Dis. 2013;5:137\u201340.","journal-title":"Middle East J Dig Dis"},{"key":"e_1_3_4_65_1","first-page":"107","article-title":"Prevalence and risk factors of hepatitis A among blood donors in Qazvin, Central Iran","volume":"52","author":"Ramezani H","year":"2011","unstructured":"Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, Mazdaki A, Alavian SM. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, Central Iran. Singapore Med J. 2011;52:107\u201312.","journal-title":"Singapore Med J"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.26719\/2007.13.5.1108"},{"key":"e_1_3_4_67_1","first-page":"33","article-title":"Prevalence of hepatitis A virus antibodies in patients with chronic liver disease in Shiraz, Iran","volume":"24","author":"Saberifiroozi M","year":"2005","unstructured":"Saberifiroozi M, Serati AR, Taghvaee T, Marooofi GR, Shirazi KM. Prevalence of hepatitis A virus antibodies in patients with chronic liver disease in Shiraz, Iran. Indian J Gastroenterol. 2005;24:33\u201334.","journal-title":"Indian J Gastroenterol"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.6035"},{"key":"e_1_3_4_69_1","first-page":"S208","article-title":"Hepatitis A seropositivity among first-year students of the Medical University in Isfahan, Iran","volume":"5","author":"Saneian H","year":"2014","unstructured":"Saneian H, Rahimi H, Shoaei P. Hepatitis A seropositivity among first-year students of the Medical University in Isfahan, Iran. Int J Prev Med. 2014;5:S208\u201312.","journal-title":"Int J Prev Med"},{"key":"e_1_3_4_70_1","first-page":"S102","article-title":"Seroprevalence of hepatitis A in patients with chronic hepatitis C in isfahan province","volume":"3","author":"Shoaei P","year":"2012","unstructured":"Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N, Nokhodian Z, Foroughifar M. Seroprevalence of hepatitis A in patients with chronic hepatitis C in isfahan province. Int J Prev Med. 2012;3:S102\u20136.","journal-title":"Int J Prev Med"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2010.02.004"},{"key":"e_1_3_4_72_1","first-page":"285","article-title":"Seroprevalence study of hepatitis A virus in Fars province, southern Iran","volume":"11","author":"Taghavi SA","year":"2011","unstructured":"Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11:285\u201388.","journal-title":"Hepat Mon"},{"key":"e_1_3_4_73_1","first-page":"S9","article-title":"Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: a seroprevalence study","volume":"19","author":"Vakili B","year":"2014","unstructured":"Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, Yaran M. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: a seroprevalence study. J Res Med Sci. 2014;19:S9\u2013s12.","journal-title":"J Res Med Sci"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268814000806"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.26219"},{"key":"e_1_3_4_76_1","first-page":"1028","article-title":"Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children","volume":"14","author":"Al-Aziz AM","year":"2008","unstructured":"Al-Aziz AM, Awad MA. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. East Mediterr Health J. 2008;14:1028\u201335.","journal-title":"East Mediterr Health J"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.54.554"},{"key":"e_1_3_4_78_1","first-page":"804","article-title":"Cost-Effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease","volume":"14","author":"El-Karaksy H","year":"2008","unstructured":"El-Karaksy H, El-Sayed R, El-Raziky M, El-Koofy N, Mansour S. Cost-Effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease. East Mediterr Health J. 2008;14:804\u201309.","journal-title":"East Mediterr Health J"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i45.7337"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890470417"},{"key":"e_1_3_4_81_1","first-page":"529","article-title":"Screening for hepatitis A virus antibodies among a disadvantaged group of preschool children in Alexandria","volume":"75","author":"Omar AA","year":"2000","unstructured":"Omar AA, Hashish MH. Screening for hepatitis A virus antibodies among a disadvantaged group of preschool children in Alexandria. J Egypt Public Health Assoc. 2000;75:529\u201339.","journal-title":"J Egypt Public Health Assoc"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.26719\/2007.13.6.1256"},{"key":"e_1_3_4_83_1","first-page":"171","article-title":"Non-A, non-B viral hepatitis in Egypt","volume":"67","author":"Darwish MA","year":"1992","unstructured":"Darwish MA, Shaker M, Al-Kady AM. Non-A, non-B viral hepatitis in Egypt. J Egypt Public Health Assoc. 1992;67:171\u201379.","journal-title":"J Egypt Public Health Assoc"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007514030062"},{"key":"e_1_3_4_85_1","first-page":"73","article-title":"Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt","volume":"17","author":"Eldin SS","year":"2010","unstructured":"Eldin SS, Seddik I, Daef EA, Shata MT, Raafat M, Abdel Baky L, Nafeh MA. Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt. Egypt J Immunol. 2010;17:73\u201386.","journal-title":"Egypt J Immunol"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3329-0"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060516659575"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890370407"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1086\/500133"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3806-9"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.26719\/2010.16.2.134"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2013.1822"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1086\/511074"},{"key":"e_1_3_4_94_1","first-page":"254","article-title":"Hepatitis E virus coinfection with hepatotropic viruses in Egyptian children","volume":"41","author":"Zaki MS","year":"2008","unstructured":"Zaki MS, Salama OS, Mansour FA, Hossein S. Hepatitis E virus coinfection with hepatotropic viruses in Egyptian children. J Microbiol Immunol Infect. 2008;41:254\u201358.","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02751716"},{"issue":"4","key":"e_1_3_4_96_1","first-page":"195","article-title":"Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBsAg - prevalence and associated risk factors in pediatric communities of Karachi","volume":"17","author":"Aziz S","year":"2007","unstructured":"Aziz S, Muzaffar R, Hafiz S, Abbas Z, Zafar MN, Naqvi SAA, Rizvi SAUH. Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBsAg - prevalence and associated risk factors in pediatric communities of Karachi. J Coll Physicians Surg Pak. 2007;17(4):195\u201398.","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34856"},{"key":"e_1_3_4_98_1","first-page":"86","article-title":"Changing trend of viral hepatitis\u2013\u201ca twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi\u201d","volume":"60","author":"Ahmed W","year":"2010","unstructured":"Ahmed W, Qureshi H, Arif A, Alam SE. Changing trend of viral hepatitis\u2013\u201ca twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi\u201d. J Pak Med Assoc. 2010;60:86\u201389.","journal-title":"J Pak Med Assoc"},{"key":"e_1_3_4_99_1","first-page":"182","article-title":"Sero-Diagnosis for viral hepatitis in 93 patients admitted with acute hepatitis in three different teaching hospitals in Lahore","volume":"44","author":"Haider Z","year":"1994","unstructured":"Haider Z, Khan AA, Rehman K, Janjua MI, Iqbal J, Chishti MA, Qayyum A, Hasnain S, Shahzad A. Sero-Diagnosis for viral hepatitis in 93 patients admitted with acute hepatitis in three different teaching hospitals in Lahore. J Pak Med Assoc. 1994;44:182\u201384.","journal-title":"J Pak Med Assoc"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22036"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(02)00399-7"},{"issue":"1","key":"e_1_3_4_102_1","first-page":"15","article-title":"Hepatitis A virus infection \u2013 shifting epidemiology","volume":"16","author":"Waheed-Uz-Zaman T","year":"2006","unstructured":"Waheed-Uz-Zaman T, Hussain AB, Hussain T, Anwar M, Ghani E, Asad U. Hepatitis A virus infection \u2013 shifting epidemiology. J Coll Physicians Surg Pak. 2006;16(1):15\u201318.","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04268.x"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0399-077X(01)80031-7"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.007"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.453"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1984.tb00905.x"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/11.4.406"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.40"},{"key":"e_1_3_4_110_1","first-page":"69","article-title":"Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007","volume":"86","author":"Louati N","year":"2009","unstructured":"Louati N, Feki L, Rekik H, Feki H, Chaabouni M, Hammami A, Gargouri J, Karray-Hakim H. Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007. Arch Inst Pasteur Tunis. 2009;86:69\u201374.","journal-title":"Arch Inst Pasteur Tunis"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175887"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2007.09.026"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-012-0063-6"},{"key":"e_1_3_4_114_1","first-page":"201","article-title":"Serodiagnosis of acute hepatitis in adults patients: results of a prospective study in a central region of Tunisia","volume":"92","author":"Hellara O","year":"2014","unstructured":"Hellara O, Melki W, Mastouri M, Ben Chaab\u00e8ne N, Loghmari H, Ben Mansour W, Bdioui F, Safer L, Saffar H. Serodiagnosis of acute hepatitis in adults patients: results of a prospective study in a central region of Tunisia. Tunis Med. 2014;92:201\u201307.","journal-title":"Tunis Med"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v4n5p172"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1993.tb01765.x"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1989.tb00819.x"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v3n1p70"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.102"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(87)90146-5"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.1986.11748424"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i34.3927"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1992.47.357"},{"issue":"2","key":"e_1_3_4_124_1","first-page":"78","article-title":"[The circulation of the hepatitis A and B viruses in the Somali population]","volume":"7","author":"Mohamud KB","year":"1992","unstructured":"Mohamud KB, Aceti A, Mohamed OM, Pennica A, Maalin KA, Biondi R, Hagi MA, Quaranta G, Paparo SB, Celestino D, et al. [The circulation of the hepatitis A and B viruses in the Somali population]. Ann Ital Med Int. 1992;7(2):78\u201383.","journal-title":"Ann Ital Med Int"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(88)90225-8"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80222-5"},{"key":"e_1_3_4_127_1","first-page":"215","article-title":"The seroepidemiology of Hepatitis A virus in Amman, Jordan","volume":"27","author":"Battikhi MN","year":"2004","unstructured":"Battikhi MN, Battikhi EG. The seroepidemiology of Hepatitis A virus in Amman, Jordan. New Microbiol. 2004;27:215\u201320.","journal-title":"New Microbiol"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24137"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1177\/004947550003000215"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02561535"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-1047"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1258\/td.2007.053390"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2010.08.007"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199701)51:1<64::AID-JMV10>3.0.CO;2-4"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1086\/599231"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.1983.11748260"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(09)75317-5"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801005970"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890170409"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890330202"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031716"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.12.021"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00466-1"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1813575"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4235-5"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2015.20.16.21101"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-6-201303190-00005"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.18.17.20468-en"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800329"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.26719\/2015.21.3.153"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001921"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.12154"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.43.20941"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.18.20792"},{"key":"e_1_3_4_155_1","unstructured":"World Health Organization (WHO) Health emergencies. Countries in crisis; 2016 [accessed 2021 Feb 5]. http:\/\/www.emro.who.int\/eha\/countries-in-crisis\/index.html"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.4.30448"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.11"},{"key":"e_1_3_4_158_1","unstructured":"European Asylum Support Office. Latest asylum trends \u2013 2015 overview; 2015 [accessed 2021 Feb 5]. https:\/\/www.easo.europa.eu\/sites\/default\/files\/public\/LatestAsylumTrends20151.pdf"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31032-1"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2073146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T21:15:14Z","timestamp":1707167714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2073146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":158,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2073146"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2073146","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2073146"}}